Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mo D et al. – Low–dose (20 mg) enoxaparin in conjuction with low–dose aspirin treatment produced encouraging results. The findings in this study suggest that there is a case for randomized controlled trials to compare low–dose (20 mg) enoxaparin with higher doses.

Related Articles

Efficacy of aspirin for secondary prevention in patients with peripheral artery disease
Expert Review of Cardiovascular Therapy, 10/16/09    Relevance Score: 93%

Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome
Journal of Pharmacy and Pharmacology, 11/04/09    Relevance Score: 91%

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy, 10/20/09    Relevance Score: 91%

Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
The American Journal of Cardiology, 10/13/09    Relevance Score: 91%

Time-Dependent Effects of Low-Dose Aspirin on Plasma Renin Activity, Aldosterone, Cortisol, and Catecholamines
Hypertension, 10/12/09    Relevance Score: 89%

Today in Clinical Pharmacology...keeping you current

An alternative monitoring protocol for single-dose methotrexate therapy in ectopic pregnancy
American Journal of Obstetrics and Gynecology, 12/08/09

Emerging role of pemetrexed in ovarian cancer
Expert Review of Anticancer Therapy, 12/07/09

Correlates of use of antifracture therapy in older women with low bone mineral density
Journal of General Internal Medicine, 12/07/09

Today in Obstetrics...keeping you current

Systemic Arterial Vasodilation, Vasopressin, and Vasopressinase in Pregnancy
Journal of the American Society of Nephrology, 12/10/09

Proteome Differences of Placenta Between Pre-Eclampsia and Normal Pregnancy
Placenta, 12/10/09

Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial
The Lancet - Early Online Publication, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address